We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
In this episode of ETF Spotlight, I speak with Tim Seymour, CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, CEO of Amplify ETFs. We discuss cannabis investing and the Amplify Seymour Cannabis ETF (CNBS - Free Report) , which is actively managed by Tim.
Cannabis stocks & ETFs have done quite well over the past few weeks as a Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.
New Jersey, Arizona, Montana and South Dakota have voted to make recreational marijuana legal and Mississippi approved its medical use, starting next year. Medical use of marijuana is already legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC.
Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies. Further, the industry is evolving rapidly and therefore these stocks are very volatile. What lies ahead?
GW Pharmaceuticals , Canopy Growth Corporation (CGC - Free Report) , Cronos Group (CRON - Free Report) , Innovative Industrial Properties (IIPR - Free Report) , GrowGeneration (GRWG - Free Report) and Aphria are CNBS’s top holdings. What do investors need to know about these companies? We also discuss recent quarterly earnings of major cannabis companies.
Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email podcast@zacks.com.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Should You Buy Cannabis Stocks & ETFs Now?
In this episode of ETF Spotlight, I speak with Tim Seymour, CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, CEO of Amplify ETFs. We discuss cannabis investing and the Amplify Seymour Cannabis ETF (CNBS - Free Report) , which is actively managed by Tim.
Cannabis stocks & ETFs have done quite well over the past few weeks as a Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.
New Jersey, Arizona, Montana and South Dakota have voted to make recreational marijuana legal and Mississippi approved its medical use, starting next year. Medical use of marijuana is already legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC.
Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies. Further, the industry is evolving rapidly and therefore these stocks are very volatile. What lies ahead?
GW Pharmaceuticals , Canopy Growth Corporation (CGC - Free Report) , Cronos Group (CRON - Free Report) , Innovative Industrial Properties (IIPR - Free Report) , GrowGeneration (GRWG - Free Report) and Aphria are CNBS’s top holdings. What do investors need to know about these companies? We also discuss recent quarterly earnings of major cannabis companies.
Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email podcast@zacks.com.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>